Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Avatamed is a Biotechnology Research brand in Singapore. Privately held, at avatamed.com. It holds one address on record, all in Singapore. It employs 4 people, on the record. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Seed, US$1.0M. It is listed alongside three similar brands, mostly in Biotechnology Research.
UEN201928478W
| AVATAMED PTE. LTD. | UEN 201928478W |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Patient-centered global biopharmaceutical Company that provides precision oncology platform technology and solutions
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2020 to 2026 |
| Seed · 1 Apr 2020 | US$ 1.0M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Singapore entity on ACRA: AVATAMED PTE. LTD. (UEN 201928478W), high confidence.
4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Singapore only. Primary: 61 Biopolis Drive #03-14B Proteos, Singapore 138673.
One round. Latest 1 April 2020: Seed, US$1,000,000.
5 profiles list AVATAMED as a peer — 62nd percentile in Biotechnology Research. It lists ten peers of its own. Auristone Pte Ltd and Asia Genomics list it back.